Tpm3 Tropomyosin 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{infobox .infobox-gene}}
| Property | Value |
|---|---|
| Gene Symbol | TPM3 |
| Full Name | Tropomyosin 3 |
| Chromosomal Location | 1p36.22 |
| NCBI Gene ID | 7170 |
| OMIM ID | 191030 |
| Ensembl ID | ENSG00000143548 |
| UniProt ID | P06753 |
| Associated Diseases | Amyotrophic Lateral Sclerosis, [Congenital Myopathy](/diseases/congenital-myo |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
pathy), Sarcoidosis |
TPM3 encodes gamma-tropomyosin, an actin-binding protein that regulates actin filament organization in skeletal muscle and non-muscle cells. It is involved in muscle contraction, cell motility, and cytoskeletal dynamics. In neurons, TPM3 is expressed in the brain and is important for dendritic spine morphology and synaptic plasticity.
ALS: TPM3 mutations have been linked to familial amyotrophic lateral sclerosis, affecting motor neuron function.
Congenital Myopathies: Mutations cause congenital myopathies with fiber-type disproportion.
Neurodegeneration: Altered TPM3 expression may affect cytoskeletal integrity in neurodegeneration.
Cerebral cortex, Cerebellum, Spinal cord, Motor neurons
The study of Tpm3 Tropomyosin 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.